SCHEMBL8070880

SCHEMBL8070880

CCCCc1nc(C(Cl)c2ccc(-c3ccccc3)c(C#N)c2)c(CO)[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
BRS3 P32247 2/20 0.34
ALDH1A1 P00352 1/20 0.33
MAPK1 P28482 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
APLNR P35414 1/20 0.33
PPARG P37231 2/20 0.33
GRM5 P41594 1/20 0.33
PARP1 P09874 1/20 0.33
CTSA P10619 2/20 0.33
ACHE P22303 1/20 0.33
GCGR P47871 1/20 0.32
AGTR1 P30556 1/20 0.32
AGTR2 P50052 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3460737 0.89 PPARG (0.40) BRS3ALDH1A1MAPK1APLNRPPARG
SCHEMBL8076004 0.84 BRS3 (0.46) BRS3AGTR1AGTR2
SCHEMBL8741233 0.80 GCGR (0.32) BRS3ADORA3ADORA2AADORA1PPARG
SCHEMBL7325296 0.79 PPARG (0.38) BRS3ALDH1A1MAPK1APLNRPPARG
SCHEMBL6534773 0.77 BRS3 (0.54) BRS3AGTR1AGTR2
SCHEMBL3459617 0.74 ACHE (0.40) BRS3ALDH1A1MAPK1APLNRPPARG
SCHEMBL7050688 0.73 AGTR1 (0.34) BRS3PPARGAGTR1AGTR2PDE3B
SCHEMBL9274853 0.69 CYP19A1 (0.37) XDHBRS3ALDH1A1MAPK1ADORA3
SCHEMBL5311279 0.67 CYP1A2 (0.39) XDHCYP1A2CYP2C9CYP2C19NPSR1
SCHEMBL2692033 0.67 CYP19A1 (0.50) CYP1A2CYP2C9CYP2C19NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019048-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS Merck Sharp Dohme (Italia) S.P.A. (IT) 2000-07-19 EP disclosed
WO-1999016437-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS MERCK SHARP DOHME (ITALIA) S.P.A. (IT) 1999-04-08 WO disclosed